NCT03995628

Brief Summary

This research study aims to find out if a single oral dose of steroid after tonsillectomy will reduce pain and decrease the need for narcotic medications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
163

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Dec 2018

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 18, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 20, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 24, 2019

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 12, 2026

Status Verified

July 1, 2025

Enrollment Period

6.7 years

First QC Date

June 20, 2019

Last Update Submit

January 8, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean Visual Analog Score of Pain

    On postoperative days 0-6, the caregiver assesses participant pain using The Faces Pain Scale-Revised, which measures pain via a visual analog score. The visual analog score is an integer value between 0-10, where 0 represents no pain and 10 represents maximum pain. The mean visual analog score on postoperative day 1-3 and the mean visual analog score on postoperative day 4-6 will be calculated for comparison between arms of the study. Lower mean visual analog scores on days 4-6 represent a better outcome.

    Postoperative day 6

Secondary Outcomes (7)

  • Mean Opioid Consumption

    Postoperative day 6

  • Mean NSAID and Acetaminophen Consumption

    Postoperative day 6

  • Rate of Nausea and Vomiting

    Postoperative day 6

  • Diet and Activity Levels

    Postoperative day 6

  • Rate of 30-Day Readmission

    Postoperative day 30

  • +2 more secondary outcomes

Study Arms (2)

Steroid Group

EXPERIMENTAL

Participants will receive a one-time dose of oral dexamethasone at 0.5 mg/kg on the third post-operative day

Drug: Dexamethasone

No Steroid Group

PLACEBO COMPARATOR

Participants will receive placebo on third post-operative day

Drug: Placebo

Interventions

One dose of dexamethasone (0.5 mg/kg) on post-operative day 3 after tonsillectomy

Also known as: Decadron
Steroid Group

One dose of placebo on post-operative day 3 after tonsillectomy

No Steroid Group

Eligibility Criteria

Age3 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 3-12
  • Tonsillectomy with or without adenoidectomy for any indication
  • Outpatient (same day) surgery

You may not qualify if:

  • Bleeding disorder
  • Intra-operative surgical or anesthetic complication or unplanned admission
  • Pre-operative steroid use (defined as any steroid use greater than three days duration within 30 days prior to tonsillectomy)
  • Pre-operative opioid use (defined as any opioid use within 30 days prior to tonsillectomy)
  • Inability of parent/guardian to be contacted by phone for follow up
  • Inability or unwillingness of subject or legal guardian/representative to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

Related Publications (7)

  • Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain. 2001 Aug;93(2):173-183. doi: 10.1016/S0304-3959(01)00314-1.

    PMID: 11427329BACKGROUND
  • Tan GX, Tunkel DE. Control of Pain After Tonsillectomy in Children: A Review. JAMA Otolaryngol Head Neck Surg. 2017 Sep 1;143(9):937-942. doi: 10.1001/jamaoto.2017.0845.

    PMID: 28662233BACKGROUND
  • Batistaki C, Kaminiotis E, Papadimos T, Kostopanagiotou G. A Narrative Review of the Evidence on the Efficacy of Dexamethasone on Postoperative Analgesic Consumption. Clin J Pain. 2017 Nov;33(11):1037-1046. doi: 10.1097/AJP.0000000000000486.

    PMID: 28177939BACKGROUND
  • Vlok R, Melhuish TM, Chong C, Ryan T, White LD. Adjuncts to local anaesthetics in tonsillectomy: a systematic review and meta-analysis. J Anesth. 2017 Aug;31(4):608-616. doi: 10.1007/s00540-017-2310-x. Epub 2017 Jan 24.

    PMID: 28120104BACKGROUND
  • Redmann AJ, Maksimoski M, Brumbaugh C, Ishman SL. The effect of postoperative steroids on post-tonsillectomy pain and need for postoperative physician contact. Laryngoscope. 2018 Sep;128(9):2187-2192. doi: 10.1002/lary.27167. Epub 2018 Mar 24.

    PMID: 29573428BACKGROUND
  • Rosen HI, Bergh IH, Oden A, Martensson LB. Patients experiences of pain following day surgery - at 48 hours, seven days and three months. Open Nurs J. 2011;5:52-9. doi: 10.2174/1874434601105010052. Epub 2011 Jul 6.

    PMID: 21769308BACKGROUND
  • Cronin J, Kennedy U, McCoy S, An Fhaili SN, Crispino-O'Connell G, Hayden J, Wakai A, Walsh S, O'Sullivan R. Single dose oral dexamethasone versus multi-dose prednisolone in the treatment of acute exacerbations of asthma in children who attend the emergency department: study protocol for a randomized controlled trial. Trials. 2012 Aug 21;13:141. doi: 10.1186/1745-6215-13-141.

    PMID: 22909281BACKGROUND

MeSH Terms

Conditions

Tonsillitis

Interventions

DexamethasoneCalcium Dobesilate

Condition Hierarchy (Ancestors)

PharyngitisRespiratory Tract InfectionsInfectionsPharyngeal DiseasesStomatognathic DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedBenzenesulfonatesBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsArylsulfonatesArylsulfonic AcidsSulfonic AcidsSulfur AcidsSulfur Compounds

Study Officials

  • Phayvanh Pecha, MD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 20, 2019

First Posted

June 24, 2019

Study Start

December 18, 2018

Primary Completion

September 15, 2025

Study Completion

December 31, 2025

Last Updated

January 12, 2026

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

There is no plan to share IPD

Locations